Wisp does not want to encourage easy access to GLP-1s for those that don't need it, Monica Cepak, CEO of Wisp, noted, so is also requiring a photo of each patient to verify they have a weight issue
While it may not be possible to eliminate all episodes of dizziness, further investigation and trialing various interventions are worthwhile to help reduce the frequency and intensity of dizzy spells
For those who wake up in the middle of the night, he recommends a sustained release of a higher dose of melatonin
Special attention should focus on its potential interactions with standard medications for thyroid disorders (e.g., methimazole, propranolol) and diabetes (e.g., metformin) to ensure safe integration into conventional therapies and support its rational clinical use
Frequently Asked Questions How quickly will I see weight loss results on GLP-1 medication
11 This section provides an overview of clinical trials investigating GLP-1RAs, dual GLP-1/GIP agonists, and triple GLP-1/GIP/glucagon agonists, with an emphasis on their efficacy, safety, and long-term implications